Morgens Waterfall Vintiadis & CO Inc Gilead Sciences, Inc. Transaction History

Morgens Waterfall Vintiadis & CO Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $1.74 Million - $2.18 Million	-30,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $1.32 Million - $1.49 Million	-20,300 Reduced 40.36%	30,000 $2.18 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $3.4 Million - $3.67 Million	50,300 New	50,300 $7.18 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $1.78 Million - $2.09 Million	-25,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $1.8 Million - $2.14 Million	25,000	25,000 $2.03 Million

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Morgens Waterfall Vintiadis & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Morgens Waterfall Vintiadis & CO Inc with notifications on news.